Le Lézard
Classified in: Health
Subjects: NPT, LEG, LBR, VET, AVO

VA Union Says H.R. 5674 'Kicks the Door Wide Open to VA Privatization'


WASHINGTON, May 8, 2018 /PRNewswire-USNewswire/ -- In response to today's vote by the House Veterans Affairs Committee on H.R. 5674, American Federation of Government Employees National President J. David Cox Sr. issued the following statement:

H.R. 5674 kicks the door wide open to VA privatization, no matter what its supporters claim, says J. David Cox Sr., national president of the American Federation of Government Employees.

"H.R. 5674 is a privatization bill, make no mistake about that.  This legislation kicks the door wide open to VA privatization, no matter what its supporters claim.  Whoever becomes VA Secretary will have all the power necessary to undermine the comprehensive, integrated care and services now provided in-house to veterans. 

"There is no possibility that the totality of care that veterans receive today inside the VA will be replicated once they are thrown out into the private market.

"Nowhere in this 200-page bill does Congress address the serious issues confronting the VA ? inadequate funding and staffing to meet the growing demand for care at VA hospitals and clinics. Instead the focus is on sending money and veterans outside to costly and unaccountable private care and walk-in clinics that lack the ability to treat veterans' complex needs.  

"The bill also includes a plan for dismantling VA's infrastructure by means of a BRAC-style closure commission.  This VA closure Commission will be able to spend precious healthcare dollars as it compiles a list of facilities to shut down and also replaces the Congress' role in fighting for new facilities and repairs.  And Congress and the public will have virtually no say about whether to implement the recommendations of the Commission.

"This expensive BRAC process will have an open pipeline to divert precious VA health care dollars desperately needed to hire staff and fix crumbling buildings.

"The BRAC-style process should have no place in veterans' health care.  Once a VA medical center or clinic is dismantled through the Commission process, veterans who have lost that vital and preferred source of care will have only one "choice" and that is privatized, fragmented care that is both costly and unaccountable.

"Our veterans risked their lives to serve our country, and under H.R. 5674, America is thanking them by telling them receive their healthcare at strip shopping center urgent care facilities. Veterans deserve better than this, and it is absolutely clear that we will come to regret forcing our heroes into such substandard care.

"We strongly urge veterans and concerned citizens to call their Congressional Representatives and tell them to vote 'NO' on H.R. 5674 to ensure the VA is protected from privatization and able to serve veterans for years to come."

The American Federation of Government Employees (AFGE) is the largest federal employee union, representing 700,000 workers in the federal government and the government of the District of Columbia.

For the latest AFGE news and information, visit the AFGE Media Center. Follow us on Facebook, Twitter, and YouTube

AFGE logo. (PRNewsFoto/American Federation of Government Employees)

SOURCE American Federation of Government Employees


These press releases may also interest you

at 07:05
Foundation Medicine, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®Liquid CDx to be used as a companion diagnostic for AKEEGA® (niraparib and abiraterone acetate) from Janssen...

at 07:05
Novocure announced today that it will report financial results for the second quarter 2024 on Thursday, July 25, 2024, before the U.S. financial markets open. Novocure management will host a conference call and webcast to discuss the company's...

at 07:05
AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced that its Phase 1/2 ASPIRE-FTD clinical trial is now open and recruiting patients...

at 07:05
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today...

at 07:05
Genezen, a best-in-class gene therapy CDMO, today announced an agreement to acquire uniQure's commercial gene therapy operations in Lexington, MA, bringing a strategic manufacturing facility and a world-class team of employees to the company. Under...

at 07:00
Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immunology-based therapies, today announced the appointment of Orlando Oliveira as its Chief Commercial Officer. With a...



News published on and distributed by: